Intranasal Insulin to Prevent Intensive Care Unit Delirium

Clinical trial NCT07532577 · COMPLETED

Trial details

NCT number: NCT07532577
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Delirium - Postoperative

Start date: 2026-04-30
Primary completion: 2026-07-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.